C.Q. Pharmaceutical Holding Co., Ltd.
SZSE:000950.SZ
5.29 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 80,119.107 | 67,829.01 | 62,520.755 | 45,219.571 | 33,843.821 | 25,802.739 | 23,044.601 | 2,567.051 | 3,326.47 | 2,968.713 | 3,437.228 | 3,322.657 | 2,588.551 | 2,078.26 | 2,083.651 | 1,449.45 | 1,023.042 | 973.958 | 333.039 | 288.433 | 356.217 | 334.291 | 472.621 | 386.743 | 382.678 | 388.249 | 400.013 | 334.116 |
Cost of Revenue
| 73,841.458 | 62,008.78 | 56,782.329 | 40,985.178 | 30,780.268 | 23,490.692 | 20,915.695 | 2,665.674 | 3,089.043 | 2,903.712 | 3,086.184 | 2,819.314 | 2,183.614 | 1,767.285 | 1,715.628 | 1,060.335 | 655.091 | 612.136 | 320.752 | 295.267 | 361.036 | 341.838 | 404.652 | 318.581 | 312.798 | 303.492 | 313.422 | 263.893 |
Gross Profit
| 6,277.65 | 5,820.231 | 5,738.426 | 4,234.393 | 3,063.554 | 2,312.047 | 2,128.906 | -98.623 | 237.427 | 65.002 | 351.044 | 503.343 | 404.937 | 310.975 | 368.023 | 389.115 | 367.951 | 361.822 | 12.287 | -6.834 | -4.819 | -7.547 | 67.969 | 68.162 | 69.88 | 84.757 | 86.59 | 70.224 |
Gross Profit Ratio
| 0.078 | 0.086 | 0.092 | 0.094 | 0.091 | 0.09 | 0.092 | -0.038 | 0.071 | 0.022 | 0.102 | 0.151 | 0.156 | 0.15 | 0.177 | 0.268 | 0.36 | 0.371 | 0.037 | -0.024 | -0.014 | -0.023 | 0.144 | 0.176 | 0.183 | 0.218 | 0.216 | 0.21 |
Reseach & Development Expenses
| 1.612 | 3.236 | 10.043 | 2.673 | 2.85 | 0.243 | 0.002 | 6.277 | 19.235 | 0 | 0.302 | 3.246 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 305.372 | 305.91 | 239.455 | 189.847 | 118.981 | 108.38 | 188.678 | 76.152 | 119.246 | 49.012 | 68.894 | 91.393 | 114.617 | 59.698 | 61.443 | 48.362 | 46.536 | 62.919 | 29.791 | 31.624 | 58.769 | 47.015 | 38.081 | 25.711 | 22.643 | 26.838 | 27.402 | 28.668 |
Selling & Marketing Expenses
| 951.995 | 2,038.375 | 2,003.898 | 1,418.589 | 1,026.834 | 826.772 | 775.647 | 153.828 | 167.626 | 174.483 | 170.242 | 144.568 | 76.639 | 63.404 | 66.571 | 69.364 | 64.178 | 63.397 | 5.001 | 5.284 | 7.862 | 10.024 | 9.744 | 7.077 | 5.889 | 5.285 | 6.051 | 3.361 |
SG&A
| 1,257.367 | 2,344.285 | 2,243.353 | 1,608.436 | 1,145.815 | 935.151 | 964.325 | 229.981 | 286.871 | 223.495 | 239.137 | 235.962 | 191.256 | 123.102 | 128.014 | 117.726 | 110.714 | 126.317 | 34.792 | 36.908 | 66.631 | 57.039 | 47.825 | 32.788 | 28.532 | 32.122 | 33.453 | 32.028 |
Other Expenses
| 4,011.575 | 1,104.737 | 981.53 | 719.317 | 513.754 | 431.916 | 400.312 | 10.494 | 10.911 | 2.273 | 63.13 | 0.189 | 1.944 | 1.609 | 0.921 | -0.015 | -1.124 | -0.05 | 3.502 | 69.979 | -52.652 | -13.052 | 0.024 | 0.391 | 4.659 | 0.631 | 1.353 | 0.546 |
Operating Expenses
| 5,270.555 | 3,452.258 | 3,234.927 | 2,330.426 | 1,662.419 | 1,367.31 | 1,364.639 | 343.012 | 427.607 | 328.696 | 327.008 | 310.994 | 244.145 | 165.928 | 128.292 | 117.749 | 110.952 | 126.376 | 35.761 | 37.532 | 67.715 | 58.118 | 50.221 | 35.326 | 30.718 | 33.809 | 34.955 | 33.357 |
Operating Income
| 1,007.095 | 2,740.411 | 2,970.398 | 2,189.147 | 1,683.199 | 1,144.281 | 1,256.127 | -675.579 | -374.129 | -362.592 | -53.46 | 138.481 | 106.275 | 150.975 | 239.607 | 303.654 | 242.049 | 207.293 | -47.372 | -61.308 | -91.131 | -86.234 | 5.489 | 44.274 | 29.327 | 33.327 | 37.172 | 15.492 |
Operating Income Ratio
| 0.013 | 0.04 | 0.048 | 0.048 | 0.05 | 0.044 | 0.055 | -0.263 | -0.112 | -0.122 | -0.016 | 0.042 | 0.041 | 0.073 | 0.115 | 0.209 | 0.237 | 0.213 | -0.142 | -0.213 | -0.256 | -0.258 | 0.012 | 0.114 | 0.077 | 0.086 | 0.093 | 0.046 |
Total Other Income Expenses Net
| 1.446 | -1,267.92 | -1,390.111 | -814.686 | -565.503 | -518.001 | -184.036 | 126.699 | 7.802 | -93.584 | -11.384 | -53.625 | -53.637 | 1.207 | -36.273 | 32.272 | -16.074 | -28.625 | -20.305 | 51.627 | -52.362 | -12.202 | -0.072 | -1.127 | 4.786 | 0.631 | 1.353 | 0.546 |
Income Before Tax
| 1,008.541 | 1,472.49 | 1,580.286 | 1,374.461 | 1,117.697 | 853.895 | 1,239.646 | -665.647 | -366.714 | -360.551 | 8.99 | 138.67 | 106.828 | 152.183 | 238.967 | 303.639 | 240.925 | 207.036 | -43.824 | 7.965 | -143.493 | -98.436 | 5.417 | 43.903 | 34.113 | 33.958 | 38.524 | 16.038 |
Income Before Tax Ratio
| 0.013 | 0.022 | 0.025 | 0.03 | 0.033 | 0.033 | 0.054 | -0.259 | -0.11 | -0.121 | 0.003 | 0.042 | 0.041 | 0.073 | 0.115 | 0.209 | 0.235 | 0.213 | -0.132 | 0.028 | -0.403 | -0.294 | 0.011 | 0.114 | 0.089 | 0.087 | 0.096 | 0.048 |
Income Tax Expense
| 236.042 | 309.496 | 289.613 | 227.07 | 173.349 | 102.981 | 86.825 | 0.674 | 0.23 | 0.076 | 2.938 | 18.655 | 18.22 | 21.549 | 35.644 | 30.911 | 26.334 | 35.118 | 3.711 | 70.245 | -50.339 | -9.548 | 1.065 | 6.667 | 4.482 | 11.101 | 12.713 | 5.293 |
Net Income
| 654.957 | 952.276 | 1,005.444 | 884.344 | 788.016 | 690.667 | 1,106.266 | -664.465 | -367.225 | -361.474 | 7.278 | 121.371 | 90.891 | 132.339 | 204.66 | 272.747 | 145.445 | 82.322 | -43.824 | 7.965 | -143.493 | -98.436 | 4.351 | 37.236 | 29.63 | 22.858 | 25.811 | 10.746 |
Net Income Ratio
| 0.008 | 0.014 | 0.016 | 0.02 | 0.023 | 0.027 | 0.048 | -0.259 | -0.11 | -0.122 | 0.002 | 0.037 | 0.035 | 0.064 | 0.098 | 0.188 | 0.142 | 0.085 | -0.132 | 0.028 | -0.403 | -0.294 | 0.009 | 0.096 | 0.077 | 0.059 | 0.065 | 0.032 |
EPS
| 0.38 | 0.55 | 0.58 | 0.51 | 0.46 | 0.4 | 0.64 | -0.38 | -0.61 | -0.6 | 0.02 | 0.2 | 0.15 | 0.22 | 0.33 | 0.59 | 0.49 | 0.28 | -0.14 | 0.027 | -0.45 | -0.31 | 0.015 | 0.12 | 0.1 | 0.071 | 0.081 | 0.034 |
EPS Diluted
| 0.38 | 0.55 | 0.58 | 0.51 | 0.46 | 0.4 | 0.64 | -0.38 | -0.61 | -0.6 | 0.02 | 0.2 | 0.15 | 0.22 | 0.4 | 0.59 | 0.49 | 0.28 | -0.14 | 0.027 | -0.45 | -0.31 | 0.015 | 0.12 | 0.1 | 0.071 | 0.081 | 0.034 |
EBITDA
| 2,748.611 | 2,999.776 | 2,998.524 | 2,174.73 | 1,627.685 | 916.115 | 1,656.836 | 1,080.521 | 241.288 | -17.349 | 341.234 | 376.31 | 285.394 | 314.547 | 335.397 | 314.865 | 248.884 | 318.624 | 19.508 | 65.551 | -78.01 | -31.235 | 65.519 | 68.386 | 51.108 | 50.948 | 51.635 | 36.866 |
EBITDA Ratio
| 0.034 | 0.046 | 0.053 | 0.051 | 0.052 | 0.047 | 0.077 | -0.023 | 0.089 | -0.001 | 0.095 | 0.11 | 0.11 | 0.151 | 0.163 | 0.217 | 0.243 | 0.327 | 0.059 | 0.227 | -0.219 | -0.093 | 0.139 | 0.182 | 0.135 | 0.131 | 0.129 | 0.11 |